Skip to search formSkip to main contentSkip to account menu

tedizolid

Known as: torezolid, 3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one, 2-Oxazolidinone, 3-(3-Fluoro-4-(6-(2-Methyl-2H-Tetrazol-5-yl)-3-Pyridinyl)Phenyl)-5-(Hydroxymethyl)-, (5R)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Patient: Female, 38-year-old Final Diagnosis: Peritonitis Symptoms: Abdominal and/or epigastric pain Medication:— Clinical… 
2017
2017
Objectives Tedizolid is an orally bioavailable oxazolidinone with once-daily dosing and broad-spectrum Gram-positive activity… 
Review
2017
Review
2017
Purpose of ReviewVancomycin-resistant Enterococci (VRE) infections are problematic due to limited availability of anti-VRE agents… 
2016
2016
ABSTRACT We developed a rat model of methicillin-resistant Staphylococcus epidermidis (MRSE) foreign body-associated… 
2016
2016
Tedizolid (TDZ) is a novel oxazolidinone class antibiotic, indicated for the treatment of acute bacterial skin and skin structure… 
Review
2016
Review
2016
Vancomycin has been a predominant treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections for decades… 
Review
2014
Review
2014
Introduction: Despite available treatment options for methicillin-resistant Staphylococcus aureus (MRSA), the morbidity and…